Wednesday, 27 October 2021

Exyte to build diabetes care player Dexcom's first manufacturing facility in Asia

16 April 2021 | News

Exyte is supporting Dexcom's strategic growth plans as it expands manufacturing into Asia for the first time

Image credit- prnasia

Image credit- prnasia

Exyte, world-renowned for the design and construction of high-tech facilities, has been awarded a fast-track project for Dexcom in Penang, Malaysia. This is the first manufacturing facility for the U.S.-based diabetes care technology provider outside the United States.

Exyte is supporting Dexcom's strategic growth plans as it expands manufacturing into Asia for the first time.

Located in Batu KawanPenang, and with 1.8 million square feet of gross floor area, the project will house a manufacturing facility for continuous glucose monitoring (CGM) systems.

Key parts of the facility include multi-story cleanrooms, a warehouse with dock leveller, a three-story Central Utility Building (CUB), a seven-story office building with a canteen and recreational area as well as a seven-level multi-story parking structure.

Exyte's value-added engineering capabilities and experienced team of engineers provide the right fit to complete the state-of-the-art facility in an efficient manner.

The project will enable Dexcom to quickly expand CGM production, increasing the number of systems it can deliver worldwide to meet growing demands.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account